Table 1 Comparison of clinical parameters of the patients between the training and test sets
Factors | Training set | Test set | P |
|---|---|---|---|
Gender | Â | Â | 0.082 |
  Female | 30 (58.8%) | 13 (39.4%) |  |
  Male | 21 (41.2%) | 20 (60.6%) |  |
Recurrence | Â | Â | 0.987 |
  Yes | 31 (60.8%) | 20 (60.6%) |  |
  No | 20 (39.2%) | 13 (39.4%) |  |
Age (years) | 3.4 (1.9–4.7) | 3.6 (2.8–5.3) | 0.104 |
NSE (ng/mL) | 297.6 (129.9–722.2) | 511.0 (178.6–750.0) | 0.357 |
Ferritin (ng/mL) | 162.6 (69.9–351.5) | 223.2 (118.3–342.2) | 0.262 |
LDH (U/L) | 605.0 (380.5–1114.0) | 828.0 (545.0–1258.0) | 0.234 |
VMA (µmol/L) | 197.5 (57.4–674.6) | 255.3 (87.5–620.2) | 0.780 |
HVA (µmol/L) | 52.9 (19.5–113.8) | 91.0 (32.9–182.3) | 0.189 |
NSE Neuron-specific enolase, LDH Lactate dehydrogenase, VMA Vanillylmandelic acid, HVA Homovanillic acid | |||